| Literature DB >> 30746149 |
Tiffany Yang1, Heather L Haas2, Samir Patel3, Ronald Smolowitz3, Michael C James4, Amanda S Williard1.
Abstract
We documented blood biochemistry and haematology of healthy loggerhead turtles (Caretta caretta) in the Northwest (NW) Atlantic in order to establish clinical reference intervals (RIs) for this threatened population. Blood samples were analysed from migratory loggerheads captured off the Mid-Atlantic coast of the USA in 2011, 2012, 2013 and 2016 as part of a long-term research program. Blood variables were determined using a point-of-care analyser, and a veterinary diagnostic laboratory service. We calculated 95% RIs with associated 90% confidence intervals (CIs) for each blood variable. We compared results obtained from our study of migratory loggerheads with published data for similarly sized loggerheads resident at a seasonal temperate latitude foraging area. Significant differences in several blood variables between migratory and resident turtles provided insight on energetic and health status during different behavioural states. Temperature was significantly correlated with several blood variables: lactate, pCO2, sodium, haemoglobin and lactate dehydrogenase. Our assessment of blood chemistry in healthy loggerhead turtles in the NW Atlantic provides a baseline for clinical comparisons with turtles impacted by anthropogenic and environmental threats, and highlights the importance of identifying unique aspects of biochemical and haematological profiles for sea turtles at the intra-population level.Entities:
Keywords: Reference intervals; health status; migration; physiology; sea turtle
Year: 2019 PMID: 30746149 PMCID: PMC6366141 DOI: 10.1093/conphys/coy079
Source DB: PubMed Journal: Conserv Physiol ISSN: 2051-1434 Impact factor: 3.079
Figure 1:Geographic distribution for all loggerhead turtles (Caretta caretta) captured across sampling years (A-D: 2011, 2012, 2013, 2016, respectively). The associated average sea surface temperature for each sampling period per year is provided with a colour-coded legend below the map, with each colour representing a single degree C.
Figure 2:Blood was collected from the dorsal cervical sinus of loggerhead sea turtles using a 1.5″ 20-gauge needle and 12-ml syringe.
Summary of sampling methodology by year (2011, 2012, 2013, 2016), for all loggerhead turtles (Caretta caretta) included in data analysis. Sampling methodology is characterized by capture date, key physical attributes and clinical blood analysers used for assessment. SCL_NT and Temperature are presented as Median ± SD. *n = 12
| Year | Capture Dates | SCL_NT (cm) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 2011 | 25 | June 2–6 | 72.8 ± 7.3 | 21.6 ± 1.8 | 25 | 0 | 0 | 25 | 24 |
| 2012 | 28 | May 31–June 3 | 76.2 ± 8.6 | 19.9 ± 0.9 | 27 | 28 | 0 | 28 | 28 |
| 2013 | 15 | May 21–23 | 72.9 ± 12.2 | 17.4 ± 1.9 | 10 | 15 | 0 | 15 | 12 |
| 2016 | 13 | May 17–20 | 74.1 ± 10.0* | 13.7 ± 1.3 | 13 | 0 | 12 | 0 | 0 |
| All years combined | 81 | 73.7 ± 9.2 | 19.6 ± 3.1 | 75 | 43 | 12 | 68 | 64 |
Blood analyte values for wild, healthy sub-adult loggerhead turtles captured along the shelf of the Northwest (NW) Atlantic. All blood gas values reported from the present study were measured from venous blood and temperature-corrected by internal cloacal temperature (T°C) taken upon landing of individual turtles
| Blood variable | Units | Median (Range) | Lower limit (90% CI) | Upper limit (90% CI) | Source | |
|---|---|---|---|---|---|---|
| ABS Azuro | / | 52 | 275 (48–1120) | 78.4 (59.3–106.0) | 729.9 (586.8–889.2) | VDL |
| ABS Eosino | / | 56 | 494 (0–3390) | 13.6 (2.4–41.1) | 2580.2 (1936.9–3266.2) | VDL |
| ABS Hetero | / | 63 | 3600 (900–8710) | 1308.1 (1064.3–1588.5) | 8400.9 (7246.2–9586.6) | VDL |
| ABS Lymph | / | 64 | 5770 (240–10 800) | 429.8 (0–1416.5) | 11 034.3 (10 121.9–11 841.2) | VDL |
| ABS Mono | / | 22 | 630 (0–2664) | 7.2 (0–67.1) | 2796.6 (1865.6–3974.6) | VDL |
| AG Ratiob | 61 | 0.4 (0.2–0.5) | VDL | |||
| ALP | U/l | 61 | 14 (5–84) | 3.5 (2.1–5.2) | 22.9 (20.8–24.7) | VDL |
| ALTb | U/l | 61 | 1 (0–36) | VDL | ||
| Albuminb | g/dl | 61 | 1.0 (0.5–1.9) | VDL | ||
| Anion Gap | mmol/l | 12 | 10 (−3–16) | iS–C3 | ||
| AST | U/l | 61 | 118 (71–1213) | 75.9 (71.8–80.9) | 432.7 (264.7–2674.8) | VDL |
| Azurophilsb | % | 52 | 2 (1–8) | VDL | ||
| BEecf | mmol/l | 79 | 8 (−11–23) | −5.3 (−7.4–3.1) | 21.2 (18.9–23.2) | iS–C1,2 |
| BUN | mmol/l | 12 | 9.0 (3.1–16.2) | iS–C3 | ||
| Ca | mg/dl | 61 | 7.4 (5.4–12.0) | 5.3 (5.0–5.7) | 10.3 (9.6–10.9) | VDL |
| Cholesterol | mg/dl | 61 | 104 (42–187) | 34.7 (23.6–47.2) | 167.9 (155.0–180.5) | VDL |
| CK | U/l | 61 | 928 (285–2759) | 323.3 (267.9–394.1) | 2375.8 (2013.5–2810.2) | VDL |
| Cl | mmol/l | 12 | 105 (96–113) | iS–C3 | ||
| Creatinine | μmol/l | 12 | 20 (18–27) | iS–C3 | ||
| Eosinophils | % | 56 | 4 (0–16) | 0 (0–0) | 13.7 (11.3–15.5) | VDL |
| Globulin | g/dl | 61 | 2.9 (1.7–4.6) | 1.7 (1.5–2.0) | 4.0 (3.8–4.3) | VDL |
| Glucose | mg/dl | 55 | 74 (47–332) | 39.3 (33.6–46.2) | 109.0 (100.9–116.5) | iS–C2,3 |
| Heterophils | % | 64 | 33 (14–95) | 14.8 (13.1–16.9) | 91.6 (74.8–110.5) | VDL |
| HCO3− | mmol/l | 65 | 37.9 (21.2–54.7) | 23.2 (20.6–26.0) | 52.6 (50.1–54.9) | iS–C1,2 |
| iCa | mmol/l | 54 | 0.78 (0.55–1.32) | 0.59 (0.57–0.62) | 1.23 (1.08–1.41) | iS–C2,3 |
| K | mmol/l | 55 | 3.4 (2.6–4.8) | 2.5 (2.3–2.7) | 4.4 (4.2–4.6) | iS–C2,3 |
| Lactate | mmol/l | 75 | 5.82 (0.30–19.06) | 0 (0–0.47) | 13.07 (11.70–14.19) | iS–C1 |
| LDH | IU/l | 61 | 58 (1–474) | 2.6 (1.2–5.8) | 323.0 (241.0–418.5) | VDL |
| Lymphocytes | % | 64 | 54 (4–78) | 17.2 (9.9–25.1) | 90.0 (84.1–96.3) | VDL |
| Monocytes | % | 24 | 6 (0–18) | 0 (0–0) | 16.1 (13.3–19.0) | VDL |
| Na | mmol/l | 55 | 147 (136–163) | 139.2 (137.3–141.1) | 155.3 (153.7–156.9) | iS–C2,3 |
| P | mg/dl | 61 | 5.4 (2.9–10.6) | 3.0 (2.7–3.4) | 9.3 (8.4–10.2) | VDL |
| pCO2c | mmHg | 65 | 36.1 (21.5–55.9) | 20.7 (18.9–23.0) | 58.9 (54.8–62.7) | iS–C1,2 |
| PCV/Hct | % | 54 | 37 (28–68) | 27.0 (25.4–28.6) | 46.4 (44.6–48.1) | T |
| pH | 65 | 7.521 (7.315–7.675) | 7.330 (7.295–7.367) | 7.701 (7.670–7.727) | iS–C1,2 | |
| Plasma protein | g/dl | 63 | 4.2 (2.5–33.2) | 2.4 (2.1–2.7) | 5.9 (5.6–6.3) | VDL |
| pO2 | mmHg | 65 | 67 (39–103) | 39 (35–44) | 94 (89–98) | iS–C1,2 |
| TCO2 | mmol/l | 65 | 40 (22–56) | 24 (22–27) | 55 (53–58) | iS–C1,2 |
| Total protein | g/dl | 61 | 3.9 (2.4–5.9) | 2.4 (2.2–2.7) | 5.5 (5.2–5.8) | VDL |
| Total solids | 63 | 5.0 (3.0–7.4) | 2.8 (2.2–3.1) | 7.1 (6.6–7.5) | R | |
| Uric acid | mg/dl | 61 | 1.3 (0–3.3) | 0.1 (0–0.3) | 2.4 (2.2–2.6) | VDL |
| WBC(count) | THOUS | 64 | 11.7 (3.5–15.0) | 4.8 (3.8–6.2) | 17.3 (16.2–18.2) | VDL |
| WBC(max) | THOUS | 64 | 12.7 (4.5–16.0) | 5.8 (4.8–7.3) | 18.4 (17.2–19.3) | VDL |
| WBC(min) | THOUS | 64 | 10.7 (2.5–14.0) | 3.8 (2.8–5.2) | 16.3 (15.2–17.2) | VDL |
‘Source’ is iS = i-STAT followed by cartridge type (CG4+ = C1, CG8+ = C2, CHEM8+ = C3); VDL = veterinary diagnostic laboratory; T = Hct tubes; R = refractometer.
aObservations before outlier removal.
bReference intervals and confidence intervals could not be calculated by robust methods.
cNon-Gaussian distribution following Box-Cox transformation.
Comparison of blood variables between migratory and resident turtles This table shows the median and range for each blood variable for this study (migratory turtles) and Kelly and the Holm–Bonferroni adjusted P-values obtained from the Mann–Whitney U test when comparing results. Significance was set at P ≤ 0.002. *Signifies blood variables that differ significantly between migratory and residential turtles. aSignifies a value from Kelly that was converted to the units used in our study. Please see Table 2 for sample sizes for each variable for migratory turtles. For resident turtles N = 191, unless denotedb which signifies N = 190
| Migratory median (Range) | Resident median (Range) | ||
|---|---|---|---|
| SCL_NT (cm) | 73.7 (54.9–100.8) | 63.3 (50.4–85.6) | 1.59E–14* |
| ABS Azuros (/μl) | 275 (48–1120) | 0 (0–1200)b | 4.84E–15* |
| ABS AzurosMonos (/μl) | 300 (0–2960) | 210 (0–1650)b | 2.36E–02 |
| ABS Eosinos (/μl) | 494 (0–3390) | 300 (0–4800) b | 2.02E–02 |
| ABS Hets (/μl) | 3600 (900–8710) | 4700 (0–21 600)b | 7.44E–02 |
| ABS Lymph (/μl) | 5770 (240–10 800) | 3400 (600–9200)b | 3.61E–07* |
| ABS Monos (/μl) | 630 (0–2664) | 1400 (0–1600)b | 4.31E–05* |
| Albumin (g/dl) | 1.0 (0.5–1.9) | 1.1 (0.4–1.7) | 1.00E+00 |
| AST (U/l) | 118 (71–1213) | 161.0 (50.0–390.0) | 1.43E–05* |
| BUN (mmol/l) | 9.0 (3.1–16.2) | 23.6 (6.1–67.8) | 3.61E–06* |
| Ca (mg/dl) | 7.4 (5.4–12.0) | 7.6 (5.2–11.6) | 1.00E+00 |
| CK (U/l) | 928 (285–2759) | 1034.0 (153.0–13 310.0) | 1.00E+00 |
| Cl (mmol/l) | 105 (96–113) | 115.0 (101.0–129.0) | 5.52E–05* |
| Globulin (g/dl) | 2.9 (1.7–4.6) | 2.4 (1.3–4.6)a | 1.65E–07* |
| Glucose (mg/dl) | 74 (47–332) | 104 (45.233) | 8.71E–13* |
| K (mg/dl) | 3.4 (2.6–4.8) | 4.2 (2.5–6.1) | 4.91E–12* |
| Na (mEq/l) | 147 (136–163) | 156.0 (145.0–168.0) | 4.84E–15* |
| P (mg/dl) | 5.4 (2.9–10.6) | 6.8 (3.7–11.1)a | 4.00E–09* |
| PCV (%) | 37 (28–68) | 31.0 (9.0–40.0)b | 6.86E–15* |
| Total protein (g/dl) | 3.9 (2.4–5.9) | 3.5 (2.1–6.0)a | 5.37E–04* |
| UA (mg/dl) | 1.3 (0–3.3) | 0.8 (0.1–2.8)a | 1.53E–04* |
| WBC (THOUS.) | 11.7 (3.5–15.0) | 9.0 (2.0–27.0)b | 1.59E–01 |